Qualcomm has reiterated it would like a stake in Arm and help create a consortium that would keep the Brit chip designer neutral, or out of the hands of any single chip company at least.
The latest development in the Arm IPO saga comes from Qualcomm’s chief executive, Cristiano Amon, who told the Financial Times that his company was interested in investing in Arm, and that Qualcomm could join forces with other chipmakers to buy Arm outright from owner SoftBank.
“It’s a very important asset and it’s an asset which is going to be essential to the development of our industry,” Amon said.
Qualcomm could be key in this as the chipmaker is one of Arm’s bigger licensees: its Arm-based Snapdragon chips power a great many smartphones and other mobile devices.
This makes Qualcomm just the latest of several companies that have expressed an interest in owning at least a stake in Arm. Earlier this year, Park Jung-ho, co-CEO of Korean chipmaker SK hynix, told a meeting of the company’s shareholders that it was considering forming a consortium to buy Arm.
“We are reviewing possibly forming a consortium, together with strategic partners, to jointly acquire it,” Park Jung-ho is reported to have said.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
EU Conducts First-Ever Raids on a Company Under Foreign Subsidies Regulation
Apr 23, 2024 by
CPI
FTC Moves to Ban Non-Compete Agreements, Aiming to Boost Labor Mobility
Apr 23, 2024 by
CPI
Federal Judge Nods at $418M Deal in Real Estate Antitrust Suit
Apr 23, 2024 by
CPI
Mexican Watchdog Probes Amazon and Mercado Libre Over Loyalty Bundles
Apr 23, 2024 by
CPI
Competition Commission of India to Probe AI Landscape for Competition
Apr 23, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI